Appropriate Clinical Use of Statins: A Discussion of the Evidence, Scope, Benefits and Risk.

If you have a free hour of time and the willingness to slog through some heavy scientific terminology, this interview article with Dr. David Perlmutter, Dr. Beatrice Golomb, and Dr. Steven Sinatra is about the best analysis of statin drug use you are likely to find.  Statins are the largest selling category of ethical drugs that are used to reduce cholesterol levels and presumably heart disease.  There is reasonably strong scientific evidence that use of statins in patients with existing heart disease is beneficial, but prevailing efforts to extend statin use to all people with “high” cholesterol, would appear to be unwarranted, and in fact, increase all-cause mortality rather than lowering death rates.

If you have high cholesterol, but no existing heart disease, and you are already using or considering use of a statin drug, this article will probably change your thinking.  If you are a senior (>70 yrs), high cholesterol has actually been shown to improve mortality, making statin use even less appropriate.

Alternative Therapies in Health and Medicine. Heart Health 2013 Vol 19. SUPPL. 1


read more
OnAugust 12, 2013, posted in: Aging by admin

A New Topical Pain-Relief Product, Tendonex Hits the Shelves This Month

A New Topical Pain-Relief Product, Tendonex Hits the Shelves This Month

Ethical Alternative Products announces their latest product, Tendonex, to be available commercially this month. Tendonex
helps those suffering from chronic pain or sports-related injuries.

(PRWEB) April 16, 2013

Offering immediate and lasting relief, Tendonex is the superior solution for those looking to reduce pain in a tendon,
muscle or nerve. Released recently by Ethical Alternative Products, Tendonex is now available commercially.

Safe for all skin types, the topical pain reliever contains a highly concentrated formula of alpha lipoic acid. The benefits from alpha lipoic acid allow the Tendonex formula to counteract the free radicals associated with inflammation
and promote tissue repair. The oil can be applied to the painful area without causing a burn sensation or local irritation.

“Tendonex is a category-changing topical product that acts rapidly and provides lasting relief,” stated Gerald Bruno, Ph.D., founder of Ethical Alternative Products.

This unique formula allows for a safe alternative from drug-based pain relievers. Tendonex is useful for those suffering from a variety of pain, including but not limited to tendinitis, carpal tunnel, plantar fasciitis, muscle damage and nerve pain. The exceptional product can also help with wrinkles or skin damage.

“The dramatic pain-relief properties of Tendonex are based on an innovative formulation of alpha lipoic acid, that delivers the highest concentrations of alpha lipoic acid in a bioavailable molecular dispersion,” Bruno continued.

Providing fast and effective pain relief, Tendonex is now available commercially or can be found online.

About Ethical Alternative Products:

Ethical Alternative Products offers a unique line of scientifically based products. With a strong belief in science partnering with nature, EAP only offers products that have a substantial body of scientific and clinical studies that support product efficacy and safety. It is EAP’s singular goal to employ the pharmaceutical expertise of their management team to identify, evaluate, and supply dietary supplement products that meet the highest ethical standards.


read more
OnAugust 8, 2013, posted in: Aging, EAP In The News by admin

Healthy Aging: 3 People Who Are Changing What it Means to Age

In light of a recent article on called “3 People Who Are Changing What it Means to Age” written by Anne-Marie Botek, Ethical Alternative Products (EAP) has decided to weigh in on what it means to age in a healthy way.

The article highlights 3 influential people attempting to change what it means to age. Aging, in the U.S. culture, tends to have a negative connotation to it. One presenter, Tim Carpenter, asks his audience at every speaking event, “how many of you want to get older?” He reveals, only about half the room raises their hands, perhaps not realizing the nature of the other option.

Many people associate “dying of old age” to be a peaceful way to “go” resulting from natural causes. However Aubrey de Grey, another influential speaker, points out “death from aging is not only “natural causes”, it’s anything that mainly kills older people.” Two-thirds of the people that die every day, die from old age. Death from old age is basically anything young people do not die from.

There is a better way to go about aging so you continue to have a full life, rather than allow your body to “die of old age”. This is where healthy aging becomes important. While exercise and eating right is a key element in healthy aging, so is addressing body issues such as, joint pain, as they arise. One should not assume this is just a “natural” aspect of growing older. While supplements and regenerative medicine solutions may come at a cost, imagine all the hospital and doctor bills you will be paying in the long run if you put off the issue. A simple solution is available now. In a sense, “why put off tomorrow, when it can be done today”.

Here at EAP, healthy aging is a primary goal of ours and is the idea around a handful of our products. OmniFlex keeps joints healthy to maintain mobility, with added benefits to overall well-being. ThioGel is the premier anti-oxidant for oxidative stress, which is believed to play a major role in biological aging.

Making small changes now will not only promote a new attitude towards aging, but also increase the quality of life that we maintain as we age.,%202013

read more
OnAugust 2, 2013, posted in: Aging, Anti-Aging by admin

Combination Antioxidant Therapy May Help Fatty Liver

November 7, 2011 (National Harbor/Washington, DC) — A combination of vitamin E and alpha lipoic acid (ALA) can improve the inflammatory and steatosis scores in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis, according to the results of a study presented here at the American College of Gastroenterology 2011 Annual Scientific Meeting and Postgraduate Course.

Researchers sought to examine the effects of antioxidant combination therapy on patients with nonalcoholic fatty liver disease. Inflammation and steatosis scores improved from baseline to 6 months in patients receiving the antioxidants, compared with placebo.  Compared with placebo, combination therapy resulted in a 70% difference in change in tumor necrosis factors-alpha levels from baseline.

ALA alone or vitamin E alone were not as effective. Findings revealed a 47% difference in change between ALA monotherapy and placebo and a 49% difference in change between vitamin E monotherapy and placebo.

“ALA and vitamin E should be considered as therapy in patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis to reduce inflammation and the profibrogenic effect on the liver to preclude end-stage liver disease and hepatocellular carcinoma,” said P. Patrick Basu, MD, MRCP, AGAF, FACG, assistant clinical professor of medicine at Columbia University College of Physicians & Surgeons in New York City, clinical professor at Hofstra University Medical School, and division chief of the Department of Gastroenterology and Gastrointestinal Endoscopy at North Shore University Hospital in Hempstead, New York.

Nonalcoholic fatty liver disease is the most common liver disease in the world, and a global epidemic, Dr. Basu noted. In the United States, 20% of the general population and 75% to 92% of the morbidly obese population suffer from the disease.  In the disease, excess carbohydrates and lipids can affect metabolic pathways, increasing fatty acid levels in the liver, which can lead to liver damage, according to Dr. Basu.

Factors linked to nonalcoholic fatty liver disease include obesity, hyperlipidemia, and inflammation. The disease spectrum associated with it ranges from simple steatosis to nonalcoholic steatohepatitis, cirrhosis associated with nonalcoholic fatty liver disease, and end-stage liver disease.

This study builds on earlier studies that tied individual antioxidant treatments, such as vitamin E and ALA, to improved liver pathology and diagnostic end points. Dr. Basu chose ALA because of its panantioxidant effect, he said.

The trial was a randomized, placebo-controlled, open-label, prospective clinical trial that involved 155 patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis and a body mass index from 28 to 33 kg/m². Patients were excluded from the study if they had diabetes, hepatitis B, hepatitis C, hypothyroidism, or syndromes with known insulin resistance; consumed more than 30 g of alcohol per day; or took any other medications, including herbs and supplements. The patients followed 1 of 4 daily regimens for 6 months: 300 mg ALA; 700 IU vitamin E; 300 mg ALA + 700 IU vitamin E; or placebo.

Levels of various markers were assessed at baseline and at 6 months. Combination therapy for 6 months reduced triglycerides to reference levels (<160 mg/dL). Compared with placebo, combination therapy also resulted in a 43% difference in change of triglyceride levels from baseline, a 71% difference in change of steatosis scores from baseline, a 51% difference in change of retinol binding protein 4 (RBP4) from baseline, and a 63% difference in change of homeostasis model assessment (HOMA) scores from baseline.

The only scores that remained unchanged with antioxidant combination therapy were fibrosis scores. In all the other cases, the combination of ALA plus vitamin E was more effective than ALA or vitamin E alone.

“In conclusion, no matter what you do, how you squeeze the data, this trial is statistically significant, and this is [using] over-the-counter, very inexpensive drugs,” he told Medscape Medical News. The regimen should have no adverse effects, he added.

The most impressive effects in the study appeared in the group that received vitamin E plus ALA, noted Paul Kwo, MD, FACG, professor of medicine at Indiana University in Indianapolis, who comoderated the liver session at the conference.

Dr. Kwo also predicted a trend toward more combinations of antioxidants and other novel approaches to reduce liver injury through slightly different pathways.

Although many single studies have come out, he expects to see more research on combination therapies in the future. “Nonalcoholic fatty liver disease is a very heterogeneous disorder,” said Dr. Kwo, “so it makes sense that therapies that address different pathways in the mechanism injury might be more beneficial.”

Sandra Yin


American College of Gastroenterology (ACG) 2011 Annual Scientific Meeting and Postgraduate Course: Abstract 38. Presented November 3, 2011.


read more
OnNovember 7, 2011, posted in: Articles by admin

Getting the Miracle Molecule Where It Needs To Go by Gerald A. Bruno, Ph.D.

I have taken the liberty of describing alpha lipoic acid as the “miracle molecule” because it is among the most valuable nutritional supplements we can take for our over-all well-being. I believe that alpha lipoic acid ascends to the “miracle” level because it has a wide spectrum of biological activities that are useful in treating serious diseases, it is valuable in protecting against the formation or progression of serious diseases, and it can be a major contributor to achieving “healthy aging”.

Read the entire article here.

read more

Be a Liver Lover

Quick: what is the largest organ inside your body that weighs about three pounds, is shaped like a football that´s flat on one side and is located under your ribs on your right side? If you guessed the liver, you’re right.

Although it may not be a pretty organ it is an extremely important one that has a month-long health observance named after it by the American Liver Foundation (, called Liver Awareness Month.

Reasons to love our liver abound since this organ does all of the following, and more: saves up energy; makes bile to help break down food; keeps pollution from hurting us; stops cuts from bleeding too long; kills germs; gets rid of toxic chemicals; and helps build muscle.

According to the foundation, liver disease affects one in 10 Americans, or about 30 million people — including children.

Liver disease begins with inflammation. If left untreated, especially over time, inflamed liver tissue starts to scar or become fibrous, which is called fibrosis. If fibrosis is not treated or healed, irreversible damage can occur, called cirrhosis; this can lead to liver cancer. If the liver loses most or all of its function, a life-threatening condition called liver failure can result.

To make matters worse, there is also hepatitis C, a disease of the liver that is caused by the hepatitis C virus, or HCV. While it is fortunate that 15 to 40 percent of people who contract HCV are able to successfully fight off the virus within the first six months, sadly most of the patients who are not able to get rid of the virus wind up developing a long-term, chronic hepatitis C infection.

One of the most common reasons for liver transplants, more than four million Americans have been infected with hepatitis C and the virus is responsible for 8,000 to 10,000 deaths every year.

New Hope Emerges: Nutritional Supplementation

In recent years, enlightened medicine has brought popularity to a variety of botanical liver lovers, including milk thistle, which has been used for what we now know as liver disease since the 12th century.

Today, research often attributes milk thistle´s liver supportive effects to a compound complex in milk thistle, called silymarin, which is extracted from the milk thistle seed.

Other nutrients and herbal extracts that have attracted scientific interest, of late, in liver protection include: selenium, zinc, probiotics and branched-chain amino acids.

One nutrient, however, that has been the subject of research and which shows the greatest promise for liver health has curiously not yet attained the level of popularity enjoyed by milk thistle; it is: alpha lipoic acid.

Alpha lipoic acid (or ALA) was first discovered by University of Illinois enzymologist Irwin Gunsalus in 1948 and described and characterized by University of Texas biochemist Lester J. Reed in March 1951.

It is a natural substance that, according to ALA pioneer Burt Berkson, M.D., in the December 2007 edition of the Townsend Letter for Doctors and Patients, is the “rate-limiting factor for the production of energy from carbohydrates.” In other words, without alpha lipoic acid we could not obtain energy from the food we eat and we could not stay alive.

The first large-scale human clinical studies using alpha lipoic acid in the U.S. were conducted by Berkson, Frederick C. Bartter, M.D., and other scientists at the National Institutes of Health (NIH) in the 1970s. The researchers gave the nutrient to 79 people with severe liver damage; 75 of those, according to Berkson, recovered full liver function.

More recently, in 1999 Berkson published three case reports using a triple-antioxidant supplement regimen in patients with liver disease, including chronic hepatitis C infection. After several months of treatment with a combination of alpha lipoic acid, selenium and silymarin, all three patients recovered most or all of their liver function, avoided liver transplantation and went on to live healthy, productive lives free of the symptoms of liver disease.

James J. Gormley
September 29, 2008


read more
OnSeptember 28, 2011, posted in: Articles, Liver Disease Articles by admin

Bioavailability: Is It A Concern With Nutritional Supplements? By Gerald A. Bruno, Ph.D.

Bioavailability is a large word that is hard to spell and probably even harder to understand. Human nature being what it is, we tend to ignore things we don’t understand, unless it is impacting our lives in a meaningful way. In the world of prescription and over-the-counter drug products, bioavailability concerns are addressed by the pharmaceutical research staff of the drug company, and with the possible exception of Advil LiquiGels, these concerns seldom reach the conscious level of the average consumer. In the dietary supplement world, bioavailability of natural substances is largely ignored, with only CoQ10 products focusing significant attention on the bioavailability issue…


read more

Occupying the Middle Ground — Q&A with Ethical Alternative Products’ Founder, Gerald A. Bruno, PhD

ATH: What prompted you to create Ethical Alternative Products?

Dr. Bruno: After a long career in pharmaceutical industry research and a successful stint as an entrepreneur, I invested in a startup company that had developed an innovative formulation of the recently recognized “universal anti-oxidant” alpha lipoic acid. This product was my first real exposure to the world of natural medicines. Performing “due diligence” on alpha lipoic acid started my transition from the hard science of pharmaceutical development and conventional medicine, to the softer, gentler world of alternative medicine. Over the past ten years, I have studied a substantial number of natural substances from a scientific and personal perspective and have concluded that natural medicines offer enormous benefits to our overall well-being. Ethical Alternative Products was created as a vehicle to share my view of how these valuable natural substances could be best formulated and sometimes combined to achieve a meaningful clinical effect.

Read the entire interview here.

read more

People With OA More Sedentary Than Previously Believed

Study finds 40 percent of men and 56 percent of women with knee osteoarthritis are completely inactive.
By Jennifer Davis
It’s long been known that many arthritis patients tend to be sedentary, but a new report shows just how pervasive the problem is. The study, published in the August issue of Arthritis & Rheumatism, found that fewer than 1 in 7 men and 1 in 12 women with knee osteoarthritis, or OA, were physically active enough to meet federal guidelines. The U.S. Department of Health and Human Services recommends 150 minutes of moderate-intensity, low-impact activity per week.
In fact, 57 percent of women and 40 percent of men were classified as “inactive” – that is, they did not engage in moderate-to-vigorous activity for 10 minutes or more at any time during the course of a week.
This level of inactivity is higher than that found in earlier studies, mainly because previous studies relied on self-reporting as opposed to objective measurements.
“I think everyone knew people with arthritis were not particularly active. This proves that … it’s a major, major issue,” says study co-author Rowland W. Chang, MD, MPH, a professor of preventive medicine and rheumatology at Northwestern University’s Feinberg School of Medicine in Chicago. “The lack of physical activity is the major health issue for persons with arthritis to confront.”
Using a machine called an accelerometer to register all motion during waking hours, the researchers measured the activity of 1,111 knee OA patients between the ages of 49 and 84. Although this study didn’t compare self-reported physical activity levels with actual accelerometer data, Dr. Chang notes that most people overestimated their activity level by at least two-fold.
Dr. Chang says the study defined “moderate intensity” as activity that raises your heart rate, making you a little sweaty but still allowing you to carry on a conversation.
Physical activity is very important for people with OA: It has been shown to help reduce pain and symptoms of depression, fight fatigue, increase function and physical performance, and prevent or delay disability in knee OA, as well as improve general health and reduce the risk of several chronic diseases. An earlier study by some of the same researchers found that OA patients benefit from some physical activity even if they don’t reach the recommended 150 minutes per week, and the more they exercise, the greater the potential benefit.
“You could argue it’s an important challenge for our entire society, but for people with arthritis, it’s a particularly daunting challenge,” says Dr. Chang. “It’s a wake-up call for people with arthritis and physicians who care for them.”
Patience White, MD, vice president, public health for the Arthritis Foundation and professor of medicine and pediatrics at the George Washington School of Medicine and Health Sciences in Washington, D.C., says these numbers are sobering.
“Americans aren’t hearing the message, but people with arthritis aren’t getting it either,” says Dr. White. “I think people feel [physical activity] will make their arthritis worse. Somehow the pain makes them think something isn’t right. It’s counterintuitive to say, ‘Actually, it will make me feel better.’”
Dr. White says awareness campaigns help get the message out that physical activity is important. But she says that, as a rheumatologist, she also believes physicians have to spend time with patients to find out what individual barriers keep them from being physically active.
“I think you have to [deliver the message] on all levels, and people need to hear it five times in five different ways. So the more people who are delivering this message, the better,” Dr. White adds.
She recommends patients ask themselves why they aren’t active, and then to look for small ways throughout the day to change that, such as:
• Parking at the far end of the parking lot so your walk is a little farther.
• Scheduling a walk into your day – say, in the evening after dinner or in the morning before breakfast when you’re less busy.
• Making exercise a social event with family or friends who will hold you accountable.
• Walking around the block during your lunch break.
• Finding a fun activity, such as swimming, biking or playing an easy game of tennis.
“Figure out how you can do 10 minutes. If you are going to get the mail and you have to walk down the driveway, go up and down three times and then pick up the mail,” Dr. White suggests.
Regular physical activity can help relieve the sleep problems that dog many people with arthritis. It also can lead to weight loss, and losing just 1 pound eases 4 pounds of pressure from your knees. “People with arthritis say it’s remarkable – even just losing 5 pounds can make pain much better,” Dr. White says.
read more
OnAugust 19, 2011, posted in: Articles, Featured Stories by admin

The Pain and the Spin Stops Here

By: Gerald A. Bruno Ph.D.

February 3, 2010

The following is an account of the commercial development of a totally different approach to dealing with the pain and stiffness associated with osteoarthritis (OA). When this story began, the only available options were trying the glucosamine/chondroitin supplements or opting for a surgical joint replacement. Ten years later, these are still the options promoted by mainstream medicine, along with periodic intra-articular injections of hyaluronic acid. As a result of my having to deal with the debilitating effects of OA, and the unattractiveness of the available options, a natural product has been developed and commercialized that offers a real alternative for people dealing with debilitating joint pain.

An Unwelcome Introduction and Intrusion

I was introduced to osteoarthritis about 10 years ago, when I was in my early 60′s. The introduction was subtle and forgettable, a slight stiffness in my right knee after playing a few games of racquetball. Within a few years, the slight stiffness progressed to extreme pain and stiffness after a single game. Not really understanding the nature of the problem and being optimistic that it was a temporary problem that I could “play through”, I succeeded in precipitating a major flare-up that had me on crutches and physical therapy 3 times per week. After an X-ray of my knee, I was told that there was essentially no cartilage between the bones in my knee, and I would have to live with debilitating pain and stiffness until I cried “uncle” and had my knee replaced.

Because of my stubborn nature, and a basic mistrust of medical advice, I continued to walk, run, and play racquetball with the aid of knee braces, routine icing, and occasional NSAID use. I was severely limited in my activities, including entering and exiting a car, and driving for more than 30 minutes without severe knee pain.

At about this time, I became involved with a startup nutraceutical company and had my first conscious exposure to dietary supplements and alternative medicine. The Dietary Supplement Health and Education Act (DSHEA) had been passed in 1994, and many enterprises were being established to capitalize on the rapid growth of this new industry. With a degree in pharmaceutical science and a 15-year stint in pharmaceutical industry research, I saw an opportunity to apply more rigorous scientific scrutiny to the natural substances that could be sold under DSHEA. Despite being well into retirement age, I decided to start a dietary supplement company (Ethical Alternative Products) that focused on natural substances with a strong scientific basis for their use in restoring a healthy balance.

Fish Oil and Rosehips: The Beginning of the Answer

As I immersed myself in the world of natural healing, the constant pain in my right knee served to heighten my attention to articles dealing with osteoarthritis. When I came across a reference that suggested a synergistic benefit to taking a combination of fish oil and rosehips, I immediately started taking these products, and after a few weeks I started to feel a reduction in pain and stiffness. Being sensitive to the possibility of a placebo effect, I shared the remedy with a few friends with knee pain, and they experienced the same improvement in symptoms.

The improvement in pain and stiffness are believed to result from the anti-inflammatory properties of the omega-3′s in fish oil, and the anti-inflammatory and anti-oxidative processes attributable to the vitamins, carotenoids and galactolipids in the rosehips. The apparent synergistic effects of fish oil and rosehips were not explained.

Improving on a Good Thing

Over the next few years, I continued taking fish oil and rosehips, and continued to see the beneficial effect on pain and stiffness in my knee. I also continued my search for other natural joint supplements, and found convincing scientific and clinical evidence that krill oil, collagen type II, and pine bark extract are beneficial in reducing joint pain and stiffness. I tested these substances individually and in various combinations, until a final combination containing the five ingredients was found that profoundly reduced the pain and stiffness symptoms. The biological properties of the krill oil, collagen type II, and pine bark extract were both overlapping and complementary to the actions of the fish oil and rosehips. These ingredients added substantial anti-inflammatory and anti-oxidative activity, and also introduced the lubricating properties of hyaluronic acid (BioCell Collagen Type II contains 10% HA) and the chondrocyte stimulating properties of type II collagen.

It was fully recognized that the sample size was small, but the elimination of pain and stiffness was so dramatic, that it was decided to evaluate formulation of these five substances in a single dose capsule.

Sharing the Answer

The decision to develop a commercial joint health product was based on a large amount of scientific data on the individual ingredients and a small amount of clinical data on the efficacy of these ingredients in combination. A commercial formulation was ultimately developed that allowed the five ingredients to be filled into a single softgel capsule. The commercial product, called OmniFlex, was introduced to the market in mid-2009. Since that time it has been used by a larger number of people, and a broader database of clinical results is being tabulated. To facilitate this process, a special feedback questionnaire (based on the WOMAC osteoarthritis index), was developed and provided to users in hard-copy and website based format. Early returns have confirmed the pre-marketing clinical experience, and include some reports of dramatic reductions in pain and stiffness after taking the product for 2 – 3 weeks.

Lost in the Hype

I recently came across an article in which the CEO of a successful company was quoted as being driven by the motto “after finding the answer, you need to sell the benefits.” I think this is sound advice, but is a particularly difficult task in the natural products marketplace. The natural products consumer is continually bombarded with advertising messages that promise every imaginable health benefit. Both educated and naive consumers are at a loss to decide whether the latest product offering will help restore their health.

In this type of environment, there are two primary ways to gain attention for a product with real health benefits. Both approaches are exceedingly expensive, and generally beyond the financial capability of the typical entrepreneurial enterprise. The first approach involves spending large sums of money on advertising and promotion, so that the product becomes familiar to the consumer after repeated exposure. Since the consumer is generally incapable of separating clinical relevance from pseudo-scientific extrapolation (hype), this approach is commonly employed by enterprises that cannot demonstrate clinical product utility.

The second approach involves spending even larger sums of money to conduct controlled clinical studies, that will hopefully demonstrate the safety and efficacy of the product for the intended purpose. Depending on the intended use, controlled clinical studies can be relatively straight-forward or impossibly complex. Testing products for their effect on joint pain fits into the straight forward category, but can still cost millions of dollars. For example, a 2009 NIH-sponsored multi-center study on glucosamine/chondroitin that involved 1,583 patients at 16 rheumatology research centers cost $12.5 Million. Even though the study concluded that there was no difference between using glucosamine/chondroitin or a placebo, these products are still used by a vast number of people, confirming the effectiveness of expensive advertising.

A Small Step

Lacking the resources or inclination to pursue either of the above methods of “selling the benefits” of our new product, Ethical Alternative Products has chosen to perform a clinical study of the OmniFlex product through participation of the product users in an open-label clinical feedback program. Physicians and consumers who are using the product are being asked to complete a modified WOMAC scoring assessment that will be continuously tabulated and reported to the general public. Progress on this approach has been slow, as users tend to be reluctant to take the time to record their experience over an 8-week period, but will hopefully prove successful as use of the product spreads.

It’s Personal

I decided to take the somewhat unorthodox approach of sharing my personal experience in developing a joint health product, because the product has had a profound impact on the quality of my life. Contrary to conventional wisdom, I have been able to maintain a very active lifestyle, without resorting to surgical replacement of my knee joint. I fully recognize that this story will be perceived by some as another form of over-selling the benefit of a new supplement product, but I challenge the doubters to try the product for 2 to 3 weeks and add your experience to our clinical database. I spent a number of years optimizing the formulation and I am happy to share the answer with fellow sufferers for the expenditure of much less effort.


Author Resource:- Gerald A. Bruno, Ph.D. is the Founder and President of Ethical Alternative Products, Wyckoff NJ. Jerry graduated from the Purdue University School of Pharmacy. He has spent considerable time in pharmaceutical industry reserach and also in entreprenurial activities in the healthcare field.


read more
OnMarch 19, 2011, posted in: Articles, Featured Stories by admin